HQ Function

Serves as the central hub for PPMD's operations, including coordinating research funding, leading advocacy efforts at a national level, developing educational programs, and managing community support initiatives.

Notable Features:

Located in the heart of the nation's capital, providing strategic access to policymakers and regulatory agencies. The office is designed to be a collaborative space for staff and visiting community members.

Work Culture:

Mission-driven and passionate, with a strong sense of community and dedication to the families affected by Duchenne. The environment is collaborative, empathetic, and focused on making a tangible impact.

HQ Significance:

The Washington D.C. location underscores PPMD's commitment to advocacy and influencing public policy related to Duchenne research, drug approval, and patient care.

Values Reflected in HQ: The headquarters embodies PPMD's values of dedication, collaboration, and relentless pursuit of treatments and a cure for Duchenne, strategically positioned to maximize its advocacy impact.

Location:

While headquartered in the U.S., Parent Project Muscular Dystrophy has a significant global impact. PPMD collaborates with international researchers, patient advocacy groups, and pharmaceutical companies worldwide to accelerate the development of Duchenne therapies. They share best practices in care, support global clinical trials, and advocate for the Duchenne community on an international stage, fostering a global fight against the disease.

Street Address:

1012 14th Street NW, Suite 500

City:

Washington

State/Province:

D.C.

Country:

USA